
IH Valuation
Ihuman Inc
- Overview
- Forecast
- Valuation
- Earnings
IH Relative Valuation
IH's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, IH is overvalued; if below, it's undervalued.
Historical Valuation
Ihuman Inc (IH) is now in the Undervalued zone, suggesting that its current forward PS ratio of 0.83 is considered Undervalued compared with the five-year average of 6.35. The fair price of Ihuman Inc (IH) is between 3.36 to 3.91 according to relative valuation methord. Compared to the current price of 2.55 USD , Ihuman Inc is Undervalued By 24.2%.
Relative Value
Fair Zone
3.36-3.91
Current Price:2.55
24.2%
Undervalued
9.11
PE
1Y
3Y
5Y
Trailing
Forward
0.00
EV/EBITDA
Ihuman Inc. (IH) has a current EV/EBITDA of 0.00. The 5-year average EV/EBITDA is 7.21. The thresholds are as follows: Strongly Undervalued below -124.55, Undervalued between -124.55 and -58.67, Fairly Valued between 73.08 and -58.67, Overvalued between 73.08 and 138.96, and Strongly Overvalued above 138.96. The current Forward EV/EBITDA of 0.00 falls within the Historic Trend Line -Fairly Valued range.
-0.59
EV/EBIT
Ihuman Inc. (IH) has a current EV/EBIT of -0.59. The 5-year average EV/EBIT is -116.57. The thresholds are as follows: Strongly Undervalued below -1107.88, Undervalued between -1107.88 and -612.22, Fairly Valued between 379.09 and -612.22, Overvalued between 379.09 and 874.74, and Strongly Overvalued above 874.74. The current Forward EV/EBIT of -0.59 falls within the Historic Trend Line -Fairly Valued range.
0.83
PS
Ihuman Inc. (IH) has a current PS of 0.83. The 5-year average PS is 1.74. The thresholds are as follows: Strongly Undervalued below -2.52, Undervalued between -2.52 and -0.39, Fairly Valued between 3.87 and -0.39, Overvalued between 3.87 and 6.00, and Strongly Overvalued above 6.00. The current Forward PS of 0.83 falls within the Historic Trend Line -Fairly Valued range.
0.00
P/OCF
Ihuman Inc. (IH) has a current P/OCF of 0.00. The 5-year average P/OCF is 1.52. The thresholds are as follows: Strongly Undervalued below -5.68, Undervalued between -5.68 and -2.08, Fairly Valued between 5.12 and -2.08, Overvalued between 5.12 and 8.72, and Strongly Overvalued above 8.72. The current Forward P/OCF of 0.00 falls within the Historic Trend Line -Fairly Valued range.
0.00
P/FCF
Ihuman Inc. (IH) has a current P/FCF of 0.00. The 5-year average P/FCF is 0.00. The thresholds are as follows: Strongly Undervalued below 0.00, Undervalued between 0.00 and 0.00, Fairly Valued between 0.00 and 0.00, Overvalued between 0.00 and 0.00, and Strongly Overvalued above 0.00. The current Forward P/FCF of 0.00 falls within the Strongly Undervalued range.
Ihuman Inc (IH) has a current Price-to-Book (P/B) ratio of 1.00. Compared to its 3-year average P/B ratio of 1.03 , the current P/B ratio is approximately -2.98% higher. Relative to its 5-year average P/B ratio of -0.35, the current P/B ratio is about -387.84% higher. Ihuman Inc (IH) has a Forward Free Cash Flow (FCF) yield of approximately 0.00%. Compared to its 3-year average FCF yield of 3.17%, the current FCF yield is approximately -100.00% lower. Relative to its 5-year average FCF yield of 2.14% , the current FCF yield is about -100.00% lower.
1.00
P/B
Median3y
1.03
Median5y
-0.35
0.00
FCF Yield
Median3y
3.17
Median5y
2.14
Competitors Valuation Multiple
The average P/S ratio for IH's competitors is 2.83, providing a benchmark for relative valuation. Ihuman Inc Corp (IH) exhibits a P/S ratio of 0.83, which is -70.87% above the industry average. Given its robust revenue growth of -10.45%, this premium appears unsustainable.
Performance Decomposition
1Y
3Y
5Y
Market capitalization of IH increased by 10.87% over the past 1 year. The primary factor behind the change was an increase in Margin Expansion from 9.49 to 12.60.
The secondary factor is the Revenue Growth, contributed -10.45%to the performance.
Overall, the performance of IH in the past 1 year is driven by Margin Expansion. Which is more sustainable.
People Also Watch

VOC
VOC Energy Trust
2.710
USD
-1.09%

DBVT
Dbv Technologies SA
9.110
USD
-0.76%

IMAB
I-Mab
4.650
USD
+6.41%

AZI
Autozi Internet Technology (Global) Ltd
0.220
USD
-4.35%

XFOR
X4 Pharmaceuticals Inc
3.120
USD
-10.09%

OSS
One Stop Systems Inc
5.730
USD
-0.69%

ENTX
Entera Bio Ltd
2.030
USD
+2.53%

MVO
MV Oil Trust
5.980
USD
+0.50%

GUTS
Fractyl Health Inc
0.933
USD
-4.40%
FAQ

Is Ihuman Inc (IH) currently overvalued or undervalued?
Ihuman Inc (IH) is now in the Undervalued zone, suggesting that its current forward PS ratio of 0.83 is considered Undervalued compared with the five-year average of 6.35. The fair price of Ihuman Inc (IH) is between 3.36 to 3.91 according to relative valuation methord. Compared to the current price of 2.55 USD , Ihuman Inc is Undervalued By 24.20% .

What is Ihuman Inc (IH) fair value?

How does IH's valuation metrics compare to the industry average?

What is the current P/B ratio for Ihuman Inc (IH) as of Sep 03 2025?

What is the current FCF Yield for Ihuman Inc (IH) as of Sep 03 2025?

What is the current Forward P/E ratio for Ihuman Inc (IH) as of Sep 03 2025?
